標的がん治療のための核酸アナログベースの多機能ナノ粒子を合成するための分子認識アプローチ
Dali Wang1, Bing Liu2,3, Yuan Ma1
1School of Chemistry and Chemical Engineering, State Key Laboratory of Metal Matrix Composites, Shanghai Jiao Tong University , 800 Dongchuan Road, Shanghai 200240, China.
Journal of the American Chemical Society
|September 26, 2017
まとめ
研究者は標的を絞ったがん治療のために 新しい多機能ナノ粒子を開発しました これらのナノ粒子は 精密な薬物投与,制御された放出,そして効果的な腫瘍治療のための 同時光成像を可能にします
科学分野:
- バイオマテリアル科学
- ナノテクノロジー
- ガン 治療
背景:
- パーソナライズされた医療には 腫瘍を標的とした 効果的な薬物投与と 癌の画像検査が必要です
- 多機能ナノ粒子の開発は 先進的な癌治療戦略に不可欠です
研究 の 目的:
- 標的を絞ったがん治療のための 超分子ナノ粒子システムを作る
- 腫瘍を標的にし 薬の放出を制御し 光成像を 1つのプラットフォームに統合する
主な方法:
- アンフィフィリック前薬 (ダイオレイルクロファラビン) をミセラナノ粒子に自己組み立て
- アプタマーモチーフを含むDNAと分子認識による光探知器 (Cy5.5) の表面機能化.
- 標的薬の投与,制御された放出,および抗腫瘍効果のインビボ評価.
主要な成果:
- ナノ粒子は効率的な腫瘍標的と細胞内薬剤の放出を示した.
- 薬の投与とイメージングと 治療効果の組み合わせです
- 重要な in vivo 抗腫瘍活性が観察されました.
結論:
- 開発された超分子ナノ粒子は 癌特有の治療の有望なアプローチを提供します
- このプラットフォームは標的の薬物投与,制御された放出,リアルタイムのイメージングを容易にする.
- この戦略は パーソナライズされたがん治療の 発展の可能性を秘めています
さらに関連する動画
関連する概念動画
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Site-Targeted Drug Delivery Systems: Polymeric Carriers
36
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
36
Modified-Release Drug Delivery Systems: Site-Targeted
33
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
33
Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K


